Compound Detail
CHEMBL267777
RITANSERIN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL267777 |
| Name | RITANSERIN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | JUQLTPCYUFPYKE-UHFFFAOYSA-N |
47
Targets
99
Activities
4
Assay Types
0
PK Parameters
20
Publications
7
Known Names
1
Indications
Molecular Properties
477.6
MW (Da)
5.48
ALogP
5
HBA
0
HBD
37.6
PSA (Ų)
0.38
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Cocaine-Related Disorders
Activity Summary
Ki 56 meas. best 9.59
IC50 38 meas. best 9.4
Kd 3 meas. best 8.8
EC50 2 meas. best 5.35
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 9.59 | 9.32 | 0.3 | 3 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | IC50 | 9.4 | 9.085 | 0.4 | 2 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | IC50 | 9.4 | 9.1217 | 0.4 | 6 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 9.35 | 8.9775 | 0.5 | 4 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 9.2 | 8.47 | 0.6 | 3 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 9.15 | 8.8557 | 0.7 | 7 |
| Serotonin 2 (5-HT2) receptor CHEMBL2096671 | Ki | 9.09 | 9.09 | 0.8 | 1 |
| Rattus norvegicus CHEMBL376 | Ki | 9.05 | 8.6 | 0.9 | 2 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Kd | 8.8 | 8.8 | 1.6 | 1 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.52 | 7.635 | 3.0 | 4 |
| Rattus norvegicus CHEMBL376 | IC50 | 8.46 | 8.155 | 3.5 | 2 |
| Histamine H1 receptor CHEMBL3943 | Ki | 8.22 | 8.22 | 6.0 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 7.92 | 7.92 | 12.2 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.92 | 7.88 | 12.0 | 7 |
| 5-hydroxytryptamine receptor 7 CHEMBL3223 | Ki | 7.82 | 7.81 | 15.0 | 2 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 7.8 | 7.4933 | 15.8 | 3 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 7.54 | 7.42 | 29.0 | 2 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Kd | 7.5 | 7.5 | 31.6 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 7.45 | 7.45 | 35.5 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 7.43 | 7.3633 | 37.0 | 3 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 7.33 | 7.33 | 47.0 | 3 |
| 5-hydroxytryptamine receptor 5A CHEMBL3426 | Ki | 6.99 | 6.99 | 101.5 | 1 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 6.76 | 6.76 | 172.4 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.74 | 6.74 | 184.0 | 1 |
| D(4) dopamine receptor CHEMBL219 | Ki | 6.62 | 6.62 | 238.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Kd | 6.6 | 6.6 | 251.2 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Ki | 6.55 | 6.55 | 280.7 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 6.54 | 6.54 | 286.9 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 6.5 | 6.5 | 318.3 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 6.48 | 6.48 | 330.1 | 1 |
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 6.47 | 6.47 | 339.4 | 1 |
| Mu-type opioid receptor CHEMBL233 | Ki | 6.46 | 6.46 | 344.3 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.43 | 6.43 | 367.4 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 6.43 | 6.43 | 375.1 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 6.37 | 6.37 | 426.4 | 1 |
| D(1B) dopamine receptor CHEMBL1850 | Ki | 6.31 | 6.31 | 493.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 6.25 | 6.25 | 567.7 | 1 |
| 5-hydroxytryptamine receptor 1E CHEMBL2182 | Ki | 6.25 | 6.25 | 556.4 | 1 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 6.22 | 6.22 | 598.3 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 6.18 | 6.18 | 655.3 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 6.16 | 6.16 | 685.4 | 1 |
| Serotonin 1 (5-HT1) receptor CHEMBL2095159 | Ki | 6.08 | 6.08 | 842.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
| Kappa-type opioid receptor CHEMBL237 | Ki | 5.84 | 5.84 | 1445.4 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 5.35 | 5.35 | 4435.7 | 1 |
| GL261 CHEMBL4483239 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| U-251 CHEMBL615022 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| N-formyl peptide receptor 3 CHEMBL5646 | IC50 | 5.25 | 5.25 | 5622.5 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.1 | 5.0 | 7943.3 | 6 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 9 |
| - | 10.6019/CHEMBL4689842 | U2OS | 7 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 6 |
| 30611057 | 10.1016/j.ejmech.2018.12.061 | Diacylglycerol kinase alpha | 6 |
| 1908521 | 10.1021/jm00112a025 | Rattus norvegicus | 6 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| 1336053 | 10.1021/jm00104a006 | Rattus norvegicus | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.1016/0960-894X(94)80007-3 | Rattus norvegicus | 4 |
Data from ChEMBL 36 via Core Engine